6533b85cfe1ef96bd12bc739

RESEARCH PRODUCT

PARP inhibitor resistance induces massive genome alterations responsible of the acquisition of multidrug resistance in DNA damage repair-deficient pancreatic cancer

Martin MüllerF ArnoldJohann GoutPierre Olivier FrappartA KlegerM MoraweL PerkhoferT SeufferleinE Roger

subject

Multiple drug resistancePancreatic cancerPARP inhibitorCancer researchmedicineBiologyDNA Damage Repairmedicine.diseaseGenomehttps://doi.org/10.1055/s-0040-1716148